Last reviewed · How we verify

Noctan (METHYPRYLON)

Roche · FDA-approved approved Small molecule Quality 15/100

At a glance

Generic nameMETHYPRYLON
SponsorRoche
Drug classmethyprylon
TargetGABA-A receptor alpha-1/beta-3/gamma-2
ModalitySmall molecule
Therapeutic areaNeuroscience
PhaseFDA-approved
First approval1982

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions